Form 4: Equillium CFO Sells 10,000 Shares Under 10b5-1 Trading Plan

Equillium's Chief Financial Officer, Jason A. Keyes, sold 10,000 shares of common stock at an average price of $0.65, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Jason A. Keyes, the Chief Financial Officer of Equillium, Inc., sold 10,000 shares of common stock on January 23, 2025.
• The sale was executed under a pre-arranged 10b5-1 trading plan adopted on March 27, 2024.
• The shares were sold at a weighted average price of $0.65, with individual transaction prices ranging from $0.62 to $0.75.
• Following the transaction, Mr. Keyes directly owns 88,913 shares and indirectly owns 37,720 shares through The Keyes Trust dated September 10, 2004.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing for an insider stock sale under a pre-arranged plan. It doesn't indicate any positive or negative sentiment, but is a neutral event.

Risks

• Sales by company insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors. The use of 10b5-1 trading plans is a legal way for insiders to sell shares while avoiding accusations of trading on non-public information.

Comparison to Industry Standards

• It is common for executives at publicly traded companies to use 10b5-1 trading plans to manage their personal finances and avoid accusations of insider trading.
• The volume of shares sold by Mr. Keyes is relatively small compared to the total outstanding shares of Equillium, and is not unusual for a CFO.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The sale of shares by a company insider could potentially cause a slight negative reaction from shareholders, although the use of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Equillium, insider trading, SEC Form 4, Jason A. Keyes, 10b5-1 trading plan, stock sale, CFO, EQ